These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 39135554)

  • 1. Effects of
    Milkarizi N; Barghchi H; Belyani S; Bahari H; Rajabzade F; Ostad AN; Goshayeshi L; Nematy M; Askari VR
    Front Nutr; 2024; 11():1371137. PubMed ID: 39135554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
    Darvish Damavandi R; Shidfar F; Najafi M; Janani L; Masoodi M; Akbari-Fakhrabadi M; Dehnad A
    Phytother Res; 2021 Jun; 35(6):3145-3156. PubMed ID: 33880813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial.
    Gheflati A; Adelnia E; Nadjarzadeh A
    Phytother Res; 2019 May; 33(5):1501-1509. PubMed ID: 30895694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of purslane (Portulaca oleracea) for mild to moderate chronic hand eczema; A randomized, double-blind, placebo-controlled clinical trial.
    Heydarirad G; Rastegar S; Haji-Abdolvahab H; Fuzimoto A; Hunter J; Zare R; Pasalar M
    Explore (NY); 2024; 20(3):401-410. PubMed ID: 37872023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial.
    Fathi M; Alavinejad P; Haidari Z; Amani R
    Biol Trace Elem Res; 2020 Oct; 197(2):394-404. PubMed ID: 32020523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
    Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
    Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial.
    Barghchi H; Milkarizi N; Belyani S; Norouzian Ostad A; Askari VR; Rajabzadeh F; Goshayeshi L; Ghelichi Kheyrabadi SY; Razavidarmian M; Dehnavi Z; Sobhani SR; Nematy M
    Nutr J; 2023 Aug; 22(1):40. PubMed ID: 37605174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
    Eriksson JW; Lundkvist P; Jansson PA; Johansson L; Kvarnström M; Moris L; Miliotis T; Forsberg GB; Risérus U; Lind L; Oscarsson J
    Diabetologia; 2018 Sep; 61(9):1923-1934. PubMed ID: 29971527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of
    Bang KB; Choi JH; Park JH; Lee S; Rho MC; Lee SW; Lee S; Shin JE
    Saudi J Gastroenterol; 2022; 28(4):296-303. PubMed ID: 35848700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
    Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
    Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Evaluation of Functional Foods for Prevention of Non-alcoholic Fatty Liver Disease.
    A Mohamed D; S Abdelgayed S; A Essa H; S Mohamed R
    Pak J Biol Sci; 2018 Jan; 21(9):454-462. PubMed ID: 30724047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
    Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
    Br J Nutr; 2020 Aug; 124(4):450-456. PubMed ID: 32312333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the effects of
    Pakdel R; Vatanchian M; Niazmand S; Beheshti F; Rahimi M; Aghaee A; Hadjzadeh MA
    Drug Chem Toxicol; 2022 Jan; 45(1):14-21. PubMed ID: 31414619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
    Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zheng G; Mo F; Ling C; Peng H; Gu W; Li M; Chen Z
    Drug Des Devel Ther; 2018; 12():47-55. PubMed ID: 29343942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergestic effect of aqueous purslane (Portulaca oleracea L.) extract and fish oil on radiation-induced damage in rats.
    Abd El-Azime AS; Hussein EM; Ashry OM
    Int J Radiat Biol; 2014 Dec; 90(12):1184-90. PubMed ID: 24882390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of
    Qiao JY; Li HW; Liu FG; Li YC; Tian S; Cao LH; Hu K; Wu XX; Miao MS
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31398934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Salehi-Sahlabadi A; Kord-Varkaneh H; Kocaadam-Bozkurt B; Seraj SS; Alavian SM; Hekmatdoost A
    Phytother Res; 2022 Nov; 36(11):4201-4209. PubMed ID: 35843540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.